UB Paderborn / Katalog / Suche / in CDI

Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase

Basic & clinical pharmacology & toxicology, 2007-06, Vol.100 (6), p.392-397

2007

Volltextzugriff (PDF)

CYTOCHROMES P450 ARE DIFFERENTLY EXPRESSED IN NORMAL AND VARICOSE HUMAN SAPHENOUS VEINS: LINKAGE WITH VARICOSIS

Clinical and experimental pharmacology & physiology, 2004-05, Vol.31 (5-6), p.295-301

2004

Volltextzugriff (PDF)

Effect of HMGCoA Reductase Inhibitors on Cytochrome P450 Expression in Endothelial Cell Line

Journal of cardiovascular pharmacology, 2007-05, Vol.49 (5), p.306-315

2007

Volltextzugriff (PDF)

Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort

Journal of hypertension, 2006-11, Vol.24 (11), p.2199-2205

2006

Volltextzugriff (PDF)

Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers

European journal of pharmacology, 2005-12, Vol.527 (1), p.1-22

2005

Volltextzugriff (PDF)

Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells

Neuropharmacology, 2005-04, Vol.48 (5), p.673-684

2005

Volltextzugriff (PDF)

Mécanismes des hyperlipidémies dues aux immunosuppresseurs

Therapie, 2004-07, Vol.59 (4), p.463-469

2004

Volltextzugriff (PDF)

Pharmacogenomics of Drugs Affecting the Cardiovascular System

Clinical chemistry and laboratory medicine, 2003-04, Vol.41 (4), p.590-599

2003

Volltextzugriff (PDF)

Differential effects of human recombinant interleukin-1β and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats

Biochemical pharmacology, 1993-06, Vol.45 (11), p.2269-2277

1993

Volltextzugriff (PDF)

Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics

Toxicology and applied pharmacology, 1988, Vol.92 (1), p.141-149

1988

Volltextzugriff (PDF)

Enzyme induction by drugs and toxins

Clinica chimica acta, 1992-07, Vol.209 (1), p.109-121

1992

Volltextzugriff (PDF)

Characterization of pig liver purified cytochrome P-450 isoenzymes for ochratoxin a metabolism studies

Toxicology letters, 1991-07, Vol.57 (2), p.203-214

1991

Volltextzugriff (PDF)

Effects of RP 52028 and phenobarbital on mRNA levels of inducible and constitutive sex-specific cytochrome P450 isozymes in rat liver

Biochemical pharmacology, 1991-08, Vol.42 (5), p.1053-1060

1991

Volltextzugriff (PDF)

Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines

Cell biology and toxicology, 1989-01, Vol.5 (1), p.1-14

1989

Volltextzugriff (PDF)

Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes

Biochemical pharmacology, 1981-06, Vol.30 (12), p.1457-1461

1981

Volltextzugriff (PDF)

Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: Comparison between human and mammalian species activities

Chemico-biological interactions, 1984-01, Vol.52 (2), p.173-184

1984

Volltextzugriff (PDF)

Induction of UDP-glucuronosyltransferase isozymes in male and female rat liver microsomes by an isoquinoleine derivative (52028 RP)

Biochemical pharmacology, 1989-10, Vol.38 (20), p.3634-3638

1989

Volltextzugriff (PDF)

Immobilization of pig liver microsomes: stability of cytochrome P-450-dependent monooxygenase activities

Applied biochemistry and biotechnology, 1986-06, Vol.12 (3), p.199-213

1986

Volltextzugriff (PDF)

Manifestations of chemically induced liver damage

Clinical chemistry (Baltimore, Md.), 1995-12, Vol.41 (12 Pt 2), p.1882

1995

Volltextzugriff (PDF)

UDP-glucuronosyltransferase activities in human liver microsomes and in some laboratory animal species

Biochemical pharmacology, 1981-09, Vol.30 (17), p.2507-2510

1981

Volltextzugriff (PDF)

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1β, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes

Biochemical pharmacology, 1997-10, Vol.54 (8), p.889-898

1997

Volltextzugriff (PDF)

Dyslipidaemia and its management after immunosuppressive treatment

Therapie, 2004-07, Vol.59 (4), p.463

2004

Volltextzugriff (PDF)

Mecanismes des hyperlipidemies dues aux immunosuppresseurs: Dyslipidaemia and its Management after Immunosuppressive Treatment

Therapie, 2004-01, Vol.59 (4), p.463-469

2004

Volltextzugriff (PDF)

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin Iβ, interleukhv 6, and dexamethasone in cultured fetal rat hepatocytes

Biochemical pharmacology, 1997-10, Vol.54 (8), p.889-898

1997

Volltextzugriff (PDF)

Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamide

Pharmacological research communications, 1984-03, Vol.16 (3), p.227-241

1984

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG‐CoA Reductase

CYTOCHROMES P450 ARE DIFFERENTLY EXPRESSED IN NORMAL AND VARICOSE HUMAN SAPHENOUS VEINS: LINKAGE WITH VARICOSIS

Effect of HMGCoA Reductase Inhibitors on Cytochrome P450 Expression in Endothelial Cell Line

Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort

Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers

Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells

Mécanismes des hyperlipidémies dues aux immunosuppresseurs

Pharmacogenomics of Drugs Affecting the Cardiovascular System

Differential effects of human recombinant interleukin-1β and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats

Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics

Enzyme induction by drugs and toxins

Characterization of pig liver purified cytochrome P-450 isoenzymes for ochratoxin a metabolism studies

Effects of RP 52028 and phenobarbital on mRNA levels of inducible and constitutive sex-specific cytochrome P450 isozymes in rat liver

Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines

Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes

Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: Comparison between human and mammalian species activities

Induction of UDP-glucuronosyltransferase isozymes in male and female rat liver microsomes by an isoquinoleine derivative (52028 RP)

Immobilization of pig liver microsomes: stability of cytochrome P-450-dependent monooxygenase activities

Manifestations of chemically induced liver damage

UDP-glucuronosyltransferase activities in human liver microsomes and in some laboratory animal species

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1β, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes

Dyslipidaemia and its management after immunosuppressive treatment

Mecanismes des hyperlipidemies dues aux immunosuppresseurs: Dyslipidaemia and its Management after Immunosuppressive Treatment

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin Iβ, interleukhv 6, and dexamethasone in cultured fetal rat hepatocytes

Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamide

Suchergebnisse filtern